On June 20, 2025, SeaStar Medical announced a public offering of 4.9 million common stock shares, along with various warrants, expected to raise about $3.39 million for corporate expenses. The filing also disclosed a 20% salary cut for top executives, aimed at reducing operational costs by approximately $50,000 monthly.